Filip Małgorzata, Frankowska Małgorzata, Przegaliński Edmund
Laboratory of Drug Addiction Pharmacology, Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Eur J Pharmacol. 2007 Nov 28;574(2-3):148-57. doi: 10.1016/j.ejphar.2007.07.048. Epub 2007 Jul 31.
Preclinical and clinical findings indicate that a GABA(B) receptor agonist baclofen decreases cocaine use. The present study investigated the effects of the GABA(B) receptor antagonist (2S)-(+)-5,5-dimethyl-2-morpholineacetic acid (SCH 50911), the agonists baclofen and 3-aminopropyl(methyl)phoshinic acid (SKF 97541) and the allosteric positive modulator 3,5-bis(1,1-dimethylethyl-4-hydroxy-beta,beta-dimethylbenzenepropanol (CGP 7930) in cocaine-and food-maintained responding under a fixed ratio 5 schedule of reinforcement in male Wistar rats. The effects of the GABA(B) receptor ligands on cocaine (10 mg/kg)-induced discriminative stimulus in a two-lever, water-reinforced fixed ratio 20 task and on basal locomotor activity were also assessed. Baclofen (2.5-5 mg/kg), SKF 97541 (0.1-0.3 mg/kg) and CGP 7930 (30-100 mg/kg) decreased the cocaine (0.5 mg/kg/injection)-maintained responding; SCH 50911 (3-10 mg/kg) was inactive in this respect. Baclofen (5 mg/kg) and SKF 97541 (0.3 mg/kg), but not CGP 7930 or SCH 50911 attenuated the food-maintained responding. The inhibitory effects of the GABA(B) receptor agonists and the modulator were blocked by SCH 50911. SKF 97541 (0.1 mg/kg) or CGP 9730 (30-100 mg/kg) did not produce a significant shift in the cocaine (1.25-10 mg/kg) dose-response curve in a drug discrimination procedure, while baclofen (1.5 mg/kg) or SCH 50911 (10 mg/kg) attenuated the effects of separate doses of cocaine. Baclofen (5 mg/kg) and CGP 7930 (100 mg/kg) significantly reduced basal horizontal activity. We found that pharmacological stimulation of GABA(B) receptors by direct agonists or allosteric positive modulation reduces cocaine reinforcement while this property of cocaine is not related to tonic activation of GABA(B) receptors. The GABA(B) receptor stimulation-induced reduction of cocaine reinforcement was separated from its discriminative stimulus effects. Moreover, a dissociation between effects of direct GABA(B) receptor agonists and a GABA(B) allosteric positive modulator on cocaine vs. food-maintained responding was demonstrated.
临床前和临床研究结果表明,γ-氨基丁酸B(GABA(B))受体激动剂巴氯芬可减少可卡因的使用。本研究调查了GABA(B)受体拮抗剂(2S)-(+)-5,5-二甲基-2-吗啉乙酸(SCH 50911)、激动剂巴氯芬和3-氨基丙基(甲基)膦酸(SKF 97541)以及变构正性调节剂3,5-双(1,1-二甲基乙基)-4-羟基-β,β-二甲基苯丙醇(CGP 7930)对雄性Wistar大鼠在固定比率5强化程序下可卡因维持和食物维持反应的影响。还评估了GABA(B)受体配体对可卡因(10毫克/千克)诱导的辨别性刺激(在双杠杆、水强化固定比率20任务中)以及基础运动活动的影响。巴氯芬(2.5 - 5毫克/千克)、SKF 97541(0.1 - 0.3毫克/千克)和CGP 7930(30 - 100毫克/千克)降低了可卡因(0.5毫克/千克/注射)维持的反应;在这方面,SCH 50911(3 - 10毫克/千克)无活性。巴氯芬(5毫克/千克)和SKF 97541(0.3毫克/千克),但不是CGP 7930或SCH 50911减弱了食物维持的反应。GABA(B)受体激动剂和调节剂的抑制作用被SCH 50911阻断。在药物辨别程序中,SKF 97541(0.1毫克/千克)或CGP 9730(30 - 100毫克/千克)未使可卡因(1.25 - 10毫克/千克)剂量 - 反应曲线发生显著偏移,而巴氯芬(1.5毫克/千克)或SCH 50911(10毫克/千克)减弱了不同剂量可卡因的作用。巴氯芬(5毫克/千克)和CGP 7930(100毫克/千克)显著降低了基础水平活动。我们发现,直接激动剂或变构正性调节对GABA(B)受体的药理学刺激可降低可卡因强化作用,而可卡因的这一特性与GABA(B)受体的紧张性激活无关。GABA(B)受体刺激诱导的可卡因强化作用降低与其辨别性刺激效应是分开的。此外,还证明了直接GABA(B)受体激动剂和GABA(B)变构正性调节剂对可卡因与食物维持反应的影响存在分离。